Denton John Russel's Form 4 filing
Caris Life Sciences, Inc.CAI · filed Jun 23, 2025
- Accession no.
- 0001104659-25-061810
- Filed
- Jun 23, 2025
- Trade date
- Mar 3-Jun 20, 2025
- Filing delay
- 112 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market purchases total $157.5K. It was filed 112 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Denton John RusselCIK 0002071923 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | DReturned to the companyDisposed | −238,230 | $18.60F1 | −$4,431,078 | 16,770 | Direct | |
| Jun 18, 2025 | Common Stock | AGrant or awardAcquired | +99,321 | $0.00 | $0 | 116,091 | Direct | |
| Jun 20, 2025 | Common Stock | PPurchaseAcquired | +7,500 | $21.00 | +$157,500 | 123,591 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | AGrant or awardAcquired | +255,000 | $0.00 | $0 | 255,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents shares of Common Stock surrendered to the Issuer as repayment for an outstanding promissory note.
Referenced by the price of 1 transaction in Table I.
Remarks
Senior Vice President, General Counsel, and Secretary